1 / 2

Equine Health Market Size & Share

Equine Health Market Size & Share

Manisha109
Download Presentation

Equine Health Market Size & Share

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Equine Health Market Analysis The global equine health market is projected to grow from $2.21 billion in 2025 to $3.53 billion by 2032, with a compound annual growth rate (CAGR) of 6.9%. Market Overview  2024 Market Size: $2.08 billion  2025 Market Size: $2.21 billion  2032 Projected Size: $3.53 billion  CAGR: 6.9% (2025-2032) Regional Leadership North America dominates with 37.5% market share in 2024, driven by:  Population of 7.2 million horses in the U.S.  Well-developed infrastructure  Growing awareness of equine health products Key Growth Drivers 1.Rising prevalence of equine diseases 2.Increasing awareness of zoonotic diseases 3.Growing government support for disease prevention 4.Strategic product launches by key companies Market Segments By Product  Drug Class (dominant segment in 2024)  Vaccines  Supplemental Feed Additives By Disease Type  West Nile Virus  Equine Rabies  Equine Influenza  Equine Herpes Virus  Potomac Horse Fever  Tetanus  Others

  2. Key Market Trends The transition toward intranasal administration routes marks a significant shift in the industry. In September 2020, Boehringer Ingelheim launched Aservo EquiHaler in the U.S., the first FDA- approved inhalant therapy for horses with severe equine asthma. Leading Companies 1.Zoetis Services LLC (U.S.) 2.Ceva (France) 3.Elanco (U.S.) 4.Boehringer Ingelheim International GmbH (Germany) 5.Vetoquinol (France) 6.Neogen Corporation (U.S.) 7.Virbac (France) 8.Merck & Co., Inc. (U.S.) Recent Developments In April-March 2024, Zoetis expanded its manufacturing capabilities by acquiring a site in Melbourne, Australia, to enhance vaccine production and expanded its U.S. distribution center in Missouri. Market Challenges The industry faces two primary constraints: 1.Shortage of qualified equine veterinarians, particularly in emerging economies 2.Vaccine failure events affecting treatment efficacy Report- Fortune Business Insights - Equine Health Market Size, Share & Growth Report https://www.fortunebusinessinsights.com/industry-reports/equine-health-market-101416

More Related